From: Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort
Characteristics | Values | ||||
---|---|---|---|---|---|
Demographics | |||||
 | Min | Mean (SD) | Median | Max | |
 Age (years) | 18.00 | 52.97 (17.57) | 53.00 | 101 | |
 Body mass index (Kg/m2) | 10.72 | 24.30 (4.15) | 24.00 | 59.52 | |
 Gender | Male, n (%) | 2101 (46.19) | |||
Female, n (%) | 2448 (53.81) | ||||
 Current smoker | Yes, n (%) | 510 (11.21) | |||
No, n (%) | 4039 (88.79) | ||||
Vital signs on admission | |||||
 | Min | Mean (SD) | Median | Max | |
 Heart rate (beats/min) | 42.00 | 89.68 (14.85) | 89.00 | 143.00 | |
 Systolic blood pressure (mmHg) | 66.00 | 131.18 (18.96) | 130.00 | 222.00 | |
 Body temperature (oC) | 33.80 | 37.04 (0.80) | 36.9 | 40.40 | |
 Respiration rate (breaths/min) | 14.00 | 19.66 (3.27) | 20.00 | 98.00 | |
Comorbidities | |||||
 | Yes, n (%) | No, n (%) | |||
 Hypertension | 1255 (27.59) | 3294 (72.41) | |||
 Diabetes mellitus | 678 (14.90) | 3871 (85.10) | |||
 Dementia | 243 (5.34) | 4306 (94.66) | |||
 Malignancy | 199 (4.37) | 4350 (95.63) | |||
 Heart failure | 169 (3.72) | 4380 (96.28) | |||
 Asthma | 92 (2.02) | 4457 (97.98) | |||
 Chronic liver disease | 63 (1.38) | 4486 (98.62) | |||
 Chronic cardiac disease | 60 (1.32) | 4489 (98.68) | |||
 Chronic neurological disorder | 48 (1.06) | 4501 (98.94) | |||
 Chronic kidney disease | 44 (0.97) | 4505 (99.03) | |||
 Chronic obstructive pulmonary disease | 17 (0.37) | 4532 (99.63) | |||
 Chronic hematological disease | 16 (0.35) | 4533 (99.65) | |||
Symptoms on admission | |||||
 | Yes n (%) | No n (%) | |||
 Cough | 2330 (51.22) | 2219 (48.78) | |||
 Sputum | 1471 (32.34) | 3078 (67.66) | |||
 Headache | 993 (21.83) | 3556 (78.17) | |||
 Sore throat | 914 (20.09) | 3635 (79.91) | |||
 Myalgia | 872 (19.17) | 3677 (80.83) | |||
 Vomiting/nausea | 398 (8.75) | 4151 (91.25) | |||
 Diarrhea | 305 (6.70) | 4244 (93.30) | |||
 Fatigue/malaise | 292 (6.42) | 4257 (93.58) | |||
 Rhinorrhea | 241 (5.30) | 4308 (94.70) |